Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chipletâ„¢ platform, today announced the launch of its groundbreaking 110 GHz Low VÏ€ Intensity Modulator, featuring industry-standard ...
Cascade genetic testing (CGT) female first-degree relatives (FDR) of men with germline BRCA2 mutations (gBRCA2mut) and prostate cancer (PCa): A cost-effectiveness analysis. This is an ASCO Meeting ...
A team of researchers from the Center for Research and Innovation in Metamaterials at the University of Exeter and the Laser Processing Group at the Institute of Optics have presented in the journal ...
Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer Research UK-funded clinical trial. The TORPEdO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results